Pharma Panel: Activity & Ambition for Deal-Making to Improve the Standard of Care
Time: 11:00 am
day: Day One Part 1
Details:
- Understanding and appreciating why pharma would invest: What gap are the innovative therapies filling and how are they differentiated to improve the current standard of care?
- Which biologies invite interest and is there appetite to return to historical targets: How does this play through into prioritizing disease areas and co-morbidities of interest?
- How to drive appetite for platform investment?
- How much is the patient preference for chronic disease management a priority: How does this translate into innovation?
